Elisabetta C. Capello

Genoa, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Task-oriented virtual reality and brain functional plasticity in progressive multiple sclerosis: A randomized controlled trial on upper limb rehabilitation.

Task-oriented virtual reality and brain functional plasticity in progressive multiple sclerosis: A randomized controlled trial on upper limb rehabilitation.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: June 10, 2026

Brain Microstructural Damage as Potential Biomarker of Immune Cell-Associated Neurotoxicity Syndrome.

Brain Microstructural Damage as Potential Biomarker of Immune Cell-Associated Neurotoxicity Syndrome.

Journal: Journal of neuroimaging : official journal of the American Society of Neuroimaging

Published: November 12, 2025

Oligoclonal IgM band patterns in multiple sclerosis: A two-center study.

Oligoclonal IgM band patterns in multiple sclerosis: A two-center study.

Journal: Journal of neuroimmunology

Published: January 28, 2025

A Comprehensive Description of the Roadmap to Identify and Validate a Myelin Biomarker.

A Comprehensive Description of the Roadmap to Identify and Validate a Myelin Biomarker.

Journal: Biomarker insights

Published: December 24, 2024

The early effect of induction versus continuous therapies in active multiple sclerosis: a multimodal study on the first course of cladribine versus fingolimod.

The early effect of induction versus continuous therapies in active multiple sclerosis: a multimodal study on the first course of cladribine versus fingolimod.

Journal: Multiple sclerosis and related disorders

Published: October 01, 2024

Persistence of Treponema pallidum IgM antibodies in serum: What is their meaning?

Persistence of Treponema pallidum IgM antibodies in serum: What is their meaning?

Journal: Diagnostic microbiology and infectious disease

Published: February 27, 2024

CD19+ B cell values predict the increase of anti-SARS CoV2 antibodies in fingolimod-treated and COVID-19-vaccinated patients with multiple sclerosis.

CD19+ B cell values predict the increase of anti-SARS CoV2 antibodies in fingolimod-treated and COVID-19-vaccinated patients with multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: November 06, 2022

An eleven-year history of Vanishing White Matter Disease in an adult patient with no cognitive decline and EIF2B5 mutations. A case report.

An eleven-year history of Vanishing White Matter Disease in an adult patient with no cognitive decline and EIF2B5 mutations. A case report.

Journal: Neurocase

Published: November 09, 2021

Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis.

Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: August 05, 2021

Personalizing ocrelizumab treatment in Multiple Sclerosis: What can we learn from Sars-Cov2 pandemic?

Personalizing ocrelizumab treatment in Multiple Sclerosis: What can we learn from Sars-Cov2 pandemic?

Journal: Journal of the neurological sciences

Published: March 18, 2021

Spasticity, spastic dystonia, and static stretch reflex in hypertonic muscles of patients with multiple sclerosis.

Spasticity, spastic dystonia, and static stretch reflex in hypertonic muscles of patients with multiple sclerosis.

Journal: Clinical neurophysiology practice

Published: September 11, 2020

Autologous hematopoietic stem cell transplantation following alemtuzumab therapy in aggressive multiple sclerosis: A report of three cases.

Autologous hematopoietic stem cell transplantation following alemtuzumab therapy in aggressive multiple sclerosis: A report of three cases.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: August 26, 2020

Showing 1-12 of 45

Last Updated: 09/26/2026